[Prediction and prevention of thromboembolism in patients with hypertrophic cardiomyopathy and atrial fibrillation]

W Xu; Y M Yang

doi:10.3760/cma.j.cn112148-20210418-00348

[Prediction and prevention of thromboembolism in patients with hypertrophic cardiomyopathy and atrial fibrillation]

Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Apr 24;50(4):332-336. doi: 10.3760/cma.j.cn112148-20210418-00348.

[Article in Chinese]

Authors

W Xu¹, Y M Yang¹

Affiliation

¹ Emergency and Critical Care Center, Fuwai Hospital, National Clinical Research Center of Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.

PMID: 35399028
DOI: 10.3760/cma.j.cn112148-20210418-00348

Abstract

心房颤动（房颤）是肥厚型心肌病（HCM）患者最常合并的一种心律失常，合并房颤的HCM患者发生血栓栓塞的风险较高，而血栓栓塞也是导致此类患者死亡的主要原因。目前尚缺乏关于HCM合并房颤患者血栓栓塞风险的有效的预测模型或评分系统。在血栓栓塞防治方面，抗凝药物治疗是目前认为唯一的可有效降低HCM合并房颤患者血栓栓塞风险的方法，其他防治血栓栓塞的方法如左心耳封堵术，其循证医学证据有限，尚需进一步证实。.

MeSH terms

Atrial Fibrillation* / complications
Cardiomyopathy, Hypertrophic* / complications
Humans
Thromboembolism* / etiology
Thromboembolism* / prevention & control